13 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/13/3080073/0/en/Alzamend-Neuro-Initiates-First-Phase-II-Clinical-Trial-of-AL001-Lithium-in-Brain-Study-Taking-Place-at-Massachusetts-General-Hospital.html
19 Nov 2024
// BUSINESSWIRE
27 Apr 2022
// Nick Paul Taylor FIERCEPHARMA
https://www.fiercepharma.com/pharma/sanofi-offloads-rights-prolonged-release-antipsychotic-drug
11 May 2021
// RENAISSANCECAPITAL
https://www.renaissancecapital.com/IPO-Center/News/81644/Preclinical-Alzheimers-biotech-Alzamend-Neuro-files-for-a-$12-million-IPO#:~:text=Alzamend%20Neuro%2C%20a%20preclinical%20biotech,in%20an%20initial%20public%20offering.
09 Sep 2020
// Angus Liu FIERCE PHARMA
https://www.fiercepharma.com/marketing/intra-cellular-s-caplyta-could-cruise-toward-blockbuster-land-bipolar-depression-win
08 Sep 2020
// PSNC
https://psnc.org.uk/our-news/lithium-carbonate-added-to-the-list-of-medicines-that-cannot-be-parallel-exported-from-the-uk/